Kazuo Kawasugi Selected Research

Kazuo Kawasugi Research Topics

Disease

16	Disseminated Intravascular Coagulation 12/2021 - 01/2005
11	Thrombosis (Thrombus) 12/2021 - 01/2005
8	Infections 01/2023 - 01/2005
6	Hemorrhage 01/2023 - 01/2010
5	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 02/2011
4	Neoplasms (Cancer) 01/2023 - 08/2011
4	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 01/2007
3	Communicable Diseases (Infectious Diseases) 02/2021 - 08/2011
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 02/2007
2	Pulmonary Embolism 01/2023 - 10/2021
2	Sepsis (Septicemia) 01/2023 - 01/2013
2	Venous Thromboembolism 01/2023 - 10/2021
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 08/2011
2	Acute Promyelocytic Leukemia 04/2010 - 04/2010
1	Hematologic Diseases (Blood Diseases) 02/2021
1	Multiple Organ Failure (MODS) 02/2021
1	Leukemia 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Amyloidosis 01/2018
1	Lymphoma (Lymphomas) 01/2018
1	AIDS-Related Complex (ARC) 11/2016
1	Gastrointestinal Hemorrhage (Hematochezia) 11/2016
1	Liver Failure 01/2016
1	Hyperuricemia 01/2014
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2013
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2012
1	Burns 08/2011
1	Wounds and Injuries (Trauma) 08/2011
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2011
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2011
1	Perinatal Death 01/2011
1	Congenital Abnormalities (Deformity) 01/2011
1	Hypercalcemia (Milk Alkali Syndrome) 04/2010
1	Opportunistic Infections (Opportunistic Infection) 01/2010
1	Pdgfra-Associated Chronic Eosinophilic Leukemia 06/2006
1	Eosinophilia 06/2006
1	Cellulitis 02/2006
1	Critical Illness (Critically Ill) 01/2005

Drug/Important Bio-Agent (IBA)

18	Dacarbazine (DIC)FDA LinkGeneric 01/2023 - 01/2005
7	ThrombomodulinIBA 01/2023 - 02/2011
6	AntithrombinsIBA 01/2023 - 08/2011
4	Fibrinogen (Factor I)FDA Link 01/2023 - 08/2011
3	AnticoagulantsIBA 01/2021 - 01/2010
3	FibrinIBA 11/2016 - 09/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2011 - 04/2010
2	RivaroxabanIBA 01/2023 - 10/2021
2	CreatinineIBA 01/2023 - 01/2020
2	Thrombin FDA Link 11/2016 - 11/2012
2	Hemostatics (Antihemorrhagics)IBA 01/2013 - 08/2011
2	fibrinmonomerIBA 09/2012 - 08/2011
2	fibrin fragment D (D-dimer)IBA 09/2012 - 01/2007
1	Factor Xa InhibitorsIBA 01/2023
1	Factor XII (Hageman Factor)IBA 12/2020
1	BilirubinIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	Factor X (Stuart Factor)IBA 01/2018
1	Vitamin K FDA Link 11/2016
1	Warfarin (Coumadin)FDA LinkGeneric 11/2016
1	Uric Acid (Urate)IBA 01/2014
1	antithrombin III-protease complexIBA 01/2013
1	prothrombin fragment 1IBA 11/2012
1	thymoglobulin FDA Link 01/2012
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2012
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012
1	Vascular Endothelial Growth Factor CIBA 08/2011
1	plasmin-plasmin inhibitor complexIBA 08/2011
1	formycin diphosphate (FDP)IBA 08/2011
1	CytokinesIBA 05/2011
1	Interleukin-6 (Interleukin 6)IBA 05/2011
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2010
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2010
1	Dual-Specificity PhosphatasesIBA 02/2007
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2006
1	Imatinib Mesylate (Gleevec)FDA Link 06/2006
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 02/2006

Therapy/Procedure

6	Therapeutics 01/2023 - 01/2010
3	Drug Therapy (Chemotherapy) 11/2016 - 01/2011
2	Blood Transfusion (Blood Transfusions) 01/2020 - 01/2010
1	Transcatheter Aortic Valve Replacement 01/2020
1	Cesarean Section (Caesarean Section) 01/2011
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2010
1	Highly Active Antiretroviral Therapy (HAART) 01/2010
1	Hematopoietic Stem Cell Transplantation 01/2010